PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Complete Capabilities For Complex Projects

Leverage AMRI’s scientific expertise and state-of-the-art technology for your most complex API manufacturing challenges. AMRI offers an extensive portfolio of market-leading APIs and world-class capabilities in niche and high-barrier-to-entry technologies, as well as comprehensive analytical and solid state services that deliver strategic insights and rapid solutions.
In addition to our portfolio of more than 240 complex and custom APIs, AMRI specializes in the chemical development and cGMP manufacture of sterile and high potency APIs, steroids, generics, monobactams, boronic acids and controlled substances. We offer U.S.- and Europe-based chemical development expertise for early stage compounds, as well as custom synthesis and contract manufacturing expertise. Our technology expertise spans specialty areas such as hydrogenation, fermentation, photocatalytic chemistry, biotransformation, industrial chromatography, flow chemistry and spray drying.
 
To assess the properties and performance of your compound, AMRI offers analytical research and testing services, including solid state chemistry and container closure integrity testing. You will also have opportunities to vertically integrate your projects with our complete suite of services across our Discovery and Development, API Manufacturing and Drug Product business units.
Learn more about how we combine science and technology to deliver expert solutions for your projects. If you’ll be at CPhI Japan on April 19–21, visit us in Booth G-42. We would be happy to talk with you about your current needs.
Set up a meeting with us
Read more

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026